Perspective: plasticity, the enemy of the good

Abstract

Plasticity is an important feature of modern cancer research. However, the level at which we should consider it remains an open question. Such debate is not new in the field of cancer and can be exemplified by the different models explaining carcinogenesis. Those models mostly explain cell transformation through the deregulation of the internal circuitry. In the last years, those models dramatically increased our knowledge and led to a series of short-term successes in terms of therapeutics. However, cancer drug resistance inevitably arises. Recently, studies on the so-called tumor microenvironment enriched the cell-centered perspective but it also enlarged the complexity of cancer etiology in particular for advanced diseases. Here, we suggest that the plastic and multi-sites specific nature of cancer combined with our incapacity to promise cure should push towards a new perspective where early clinical actions, instead of late ones, should be heralded as the priority of cancer research and care.

Keywords

Resistance / plasticity / metastasis / timeline / clinical action

References

[1] Escargueil AE,Dezaire A,Larsen AK.Genotype - or phenotype-targeting anticancer therapies? Lessons from tumor evolutionary biology..Curr Pharm Des2016;22:6625-44

[2] Weinberg RA.Coming full circle-from endless complexity to simplicity and back again..Cell2014;157:267-71

[3] Bertolaso M.Philosophy of Cancer.2016;1st ed.NetherlandsSpringer

[4] Fearon ER.A genetic model for colorectal tumorigenesis..Cell1990;61:759-67

[5] Vogelstein B,Levine AJ.Surfing the p53 network..Nature2000;408:307-10

[6] Feinberg AP,Henikoff S.The epigenetic progenitor origin of human cancer..Nat Rev Genet2006;7:21-33

[7] Heng HH,Stevens JB,Liu G.Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective..J Cell Physiol2009;220:538-47

[8] Hornberg JJ,Westerhoff HV.Cancer: a systems biology disease..Biosystems2006;83:81-90

[9] Bissell MJ.Putting tumours in context..Nat Rev Cancer2001;1:46-54 PMCID:PMC2975572

[10] Bizzarri M.Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?.Biomed Res Int2014;2014:934038 PMCID:PMC4075186

[11] Park CC,Barcellos-Hoff MH.The influence of the microenvironment on the malignant phenotype..Mol Med Today2000;6:324-9

[12] Navin N,Rodgers L,Meth J.Inferring tumor progression from genomic heterogeneity..Genome Res2010;20:68-80 PMCID:PMC2798832

[13] Gerlinger M,Horswell S,Larkin J.Intratumor heterogeneity and branched evolution revealed by multiregion sequencing..N Engl J Med2012;366:883-92 PMCID:PMC4878653

[14] Greaves M.Clonal evolution in cancer..Nature2012;481:306-13 PMCID:PMC3367003

[15] Korolev KS,Gore J.Turning ecology and evolution against cancer..Nat Rev Cancer2014;14:371-80

[16] Maddipati R.Pancreatic cancer metastases harbor evidence of polyclonality..Cancer Discov2015;5:1086-97 PMCID:PMC4657730

[17] Ramirez M,Steininger RJ,Roth MA.Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells..Nat Commun2016;7:10690 PMCID:PMC4762880

[18] Ortiz-Cuaran S,Plenker D,Scheel AH.Heterogeneous mechanisms of primary and acquired resistance to third-generation egfr inhibitors..Clin Cancer Res2016;22:4837-47

[19] Le X,Negrao MV,Robichaux J.Landscape of EGFR-dependent and -independent resistance mechanisms to osimertinib and continuation therapy beyond progression in EGFR-mutant NSCLC..Clin Cancer Res2018;24:6195-203 PMCID:PMC6295279

[20] Tie J,Tomasetti C,Springer S.Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer..Sci Transl Med2016;8:346ra92 PMCID:PMC5346159

[21] Cohen JD,Thoburn C,Tie J.Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers..Proc Natl Acad Sci U S A2017;114:10202-7 PMCID:PMC5617273

[22] Leung ML,Gao R,Wang Y.Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer..Genome Res2017;27:1287-99 PMCID:PMC5538546

[23] Reiter JG,Gerold JM,Chatterjee K.Reconstructing metastatic seeding patterns of human cancers..Nat Commun2017;8:14114 PMCID:PMC5290319

[24] Small W,Bajaj A,Fisher BJ.Cervical cancer: a global health crisis..Cancer2017;123:2404-12

[25] Kan Z,Stinson J,Bhatt D.Diverse somatic mutation patterns and pathway alterations in human cancers..Nature2010;466:869-73

[26] Laplane L,Adolphs R,Mantovani A.Why science needs philosophy..Proc Natl Acad Sci U S A2019;116:3948-52